JPWO2024101382A1 - - Google Patents

Info

Publication number
JPWO2024101382A1
JPWO2024101382A1 JP2024557822A JP2024557822A JPWO2024101382A1 JP WO2024101382 A1 JPWO2024101382 A1 JP WO2024101382A1 JP 2024557822 A JP2024557822 A JP 2024557822A JP 2024557822 A JP2024557822 A JP 2024557822A JP WO2024101382 A1 JPWO2024101382 A1 JP WO2024101382A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024557822A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2024101382A1 publication Critical patent/JPWO2024101382A1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2024557822A 2022-11-09 2023-11-08 Pending JPWO2024101382A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022179712 2022-11-09
PCT/JP2023/040173 WO2024101382A1 (ja) 2022-11-09 2023-11-08 免疫チェックポイントの調節に用いるための組成物

Publications (1)

Publication Number Publication Date
JPWO2024101382A1 true JPWO2024101382A1 (https=) 2024-05-16

Family

ID=91032571

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024557822A Pending JPWO2024101382A1 (https=) 2022-11-09 2023-11-08

Country Status (2)

Country Link
JP (1) JPWO2024101382A1 (https=)
WO (1) WO2024101382A1 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015098113A1 (ja) * 2013-12-27 2015-07-02 独立行政法人医薬基盤研究所 悪性腫瘍の治療薬
JP2015532587A (ja) * 2012-06-21 2015-11-12 コンピュゲン エルティーディー. Lsr抗体およびがんの治療のためのその使用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015532587A (ja) * 2012-06-21 2015-11-12 コンピュゲン エルティーディー. Lsr抗体およびがんの治療のためのその使用
WO2015098113A1 (ja) * 2013-12-27 2015-07-02 独立行政法人医薬基盤研究所 悪性腫瘍の治療薬

Also Published As

Publication number Publication date
WO2024101382A1 (ja) 2024-05-16

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
JPWO2024101382A1 (https=)
BY13153U (https=)
BY13151U (https=)
CN307050198S (https=)
CN307049377S (https=)
CN307048892S (https=)
CN307048860S (https=)
CN307048775S (https=)
CN307048271S (https=)
CN307048195S (https=)
CN307047742S (https=)
CN307047565S (https=)
CN307047419S (https=)
CN307047247S (https=)
CN307046770S (https=)
CN307046607S (https=)
CN307046087S (https=)
CN307045835S (https=)
CN307045720S (https=)
CN307044569S (https=)
CN307026643S9 (https=)
BY13168U (https=)
BY13166U (https=)
BY13165U (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250131

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250213

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260317

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260417